↓ Skip to main content

Dove Medical Press

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy

Overview of attention for article published in OncoTargets and therapy, November 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
26 Mendeley
Title
Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
Published in
OncoTargets and therapy, November 2019
DOI 10.2147/ott.s223406
Pubmed ID
Authors

Guan-Zhang Li, Ke-Nan Zhang, Zheng Wang, Hui-Min Hu, Zhi-Liang Wang, Ruo-Yu Huang, Hao-Yu Jiang, You Zhai, Yue-Mei Feng, Yuan-Hao Chang, Ren-Peng Li, Fan Wu, Fan Zeng, Tao Jiang, Wei Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 15%
Researcher 4 15%
Student > Doctoral Student 3 12%
Student > Postgraduate 2 8%
Student > Bachelor 2 8%
Other 1 4%
Unknown 10 38%
Readers by discipline Count As %
Immunology and Microbiology 4 15%
Medicine and Dentistry 4 15%
Biochemistry, Genetics and Molecular Biology 3 12%
Psychology 1 4%
Agricultural and Biological Sciences 1 4%
Other 2 8%
Unknown 11 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2019.
All research outputs
#15,179,141
of 25,387,668 outputs
Outputs from OncoTargets and therapy
#781
of 3,016 outputs
Outputs of similar age
#197,405
of 378,069 outputs
Outputs of similar age from OncoTargets and therapy
#19
of 148 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 378,069 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 148 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.